Pfizer (PFE)

26.48
-0.05 (-0.19%)
NYSE · Last Trade: May 7th, 7:40 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close26.53
Open26.51
Bid26.49
Ask26.50
Day's Range26.16 - 26.72
52 Week Range21.97 - 28.75
Volume48,309,366
Market Cap148.47B
PE Ratio (TTM)19.47
EPS (TTM)1.4
Dividend & Yield1.720 (6.50%)
1 Month Average Volume35,577,788

Chart

About Pfizer (PFE)

Pfizer is a global biopharmaceutical company that develops and manufactures innovative medicines and vaccines to improve health outcomes for people around the world. Renowned for its extensive research and development efforts, Pfizer focuses on various therapeutic areas including vaccines, oncology, immunology, cardiology, endocrinology, and rare diseases. The company is committed to addressing significant health challenges through the discovery of new treatments, leveraging cutting-edge science and technology. Pfizer also emphasizes partnerships and collaborations to expand its capabilities and enhance access to healthcare solutions. Read More

News & Press Releases

Forget Eli Lilly: These 2 Stocks Have More Upsidefool.com
Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors.
Via The Motley Fool · May 7, 2026
What's going on in today's session: S&P500 most active stockschartmill.com
Via Chartmill · May 7, 2026
Zoetis (NYSE:ZTS) Misses Q1 CY2026 Revenue Estimates, Stock Drops 13%
Animal health company Zoetis (NYSE:ZTS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $2.26 billion. The com...
Via StockStory · May 7, 2026
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.1% year on year to $3.52 bil...
Via StockStory · May 7, 2026
Pfizer Inc. (NYSE:PFE) Tops Q1 2026 Estimates Amid Strong Non-COVID Growthchartmill.com
Via Chartmill · May 5, 2026
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skepticsfool.com
Is Pfizer a yield trap? No way.
Via The Motley Fool · May 7, 2026
History Suggests These 3 Stocks Are Due for a Major Reboundfool.com
Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies.
Via The Motley Fool · May 6, 2026
Novavax (NVAX) Q1 2026 Earnings Transcriptfool.com
Novavax (NVAX) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill...
Via StockStory · May 6, 2026
PFE Q1 Deep Dive: Oncology, Obesity Pipeline, and Legal Milestones Shape Outlook
Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ...
Via StockStory · May 6, 2026
Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetimefool.com
Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy.
Via The Motley Fool · May 5, 2026
Pfizer (PFE) Q1 2026 Earnings Transcriptfool.com
Pfizer (PFE) Q1 2026 Earnings Transcript
Via The Motley Fool · May 5, 2026
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session.chartmill.com
Via Chartmill · May 5, 2026
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue Viewbenzinga.com
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance.
Via Benzinga · May 5, 2026
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earningsbenzinga.com
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.
Via Benzinga · May 5, 2026
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th...
Via StockStory · May 5, 2026
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skepticsinvestors.com
Pfizer delivered better-than-expected sales and profit.
Via Investor's Business Daily · May 5, 2026
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2026 and reaffirmed its full-year 2026 financial guidance(2).
By Pfizer Inc. · Via Business Wire · May 5, 2026
Poets&Quants™ Names Best & Brightest MBAs of 2026
May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement
Via 24-7 Press Release · May 5, 2026
Pfizer, Pinterest And 3 Stocks To Watch Heading Into Tuesdaybenzinga.com
US stock futures up, key stocks to watch today: Pfizer, Pinterest, PayPal, ON Semiconductor, AMD. Check out Benzinga Pro's premarket coverage.
Via Benzinga · May 5, 2026
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapybenzinga.com
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer.
Via Benzinga · May 4, 2026
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effectinvestors.com
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.
Via Investor's Business Daily · May 4, 2026
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earningsbenzinga.com
Pfizer to release Q3 earnings on May 5, with analysts expecting 72 cents/share and a revenue of $13.8 billion. Annual dividend yield at 6.53%.
Via Benzinga · May 4, 2026
Eli Lilly Just Announced Fantastic News for Shareholdersfool.com
Lilly's weight loss drugs have been delivering blockbuster revenue.
Via The Motley Fool · May 4, 2026
Pfizer Earnings: What To Look For From PFE
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know. Pfizer beat analys...
Via StockStory · May 3, 2026